BeiGene plans to change name to BeOne Medicines Ltd.; ticker to become ONC

BeOne Medicines Ltd.

Name change to BeOne Medicines Ltd. subject to shareholder approval at a future meeting.
Nasdaq ticker symbol will change to 'ONC' upon completion of the name change.
Rebranding reflects commitment to develop innovative cancer medicines through global partnerships.
Shareholders urged to read definitive proxy statement when filed with the SEC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.